Breaking News
Get 45% Off 0
💰 With a 129% YTD gain in the bag, these are our AI’s top global picks for March
Read now

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
3 Zacks Rank #1 Hartford Mutual Funds In Focus By Zacks Investment Research - Nov 13, 2017

Hartford Funds, a segment of The Hartford Financial Services Group, Inc. (NYSE:HIG), has total assets of $91.5 billion under management (as of Jun 30, 2017). The company claims to manage more than 55...

Zacks Investment Research
Hess Issues Operational Update Post Enchilada Incident By Zacks Investment Research - Nov 13, 2017

Hess Corporation (NYSE:HES) has issued an update following the breakout of a fire, which affected operations at the Royal Dutch Shell (LON:RDSa) plc’s RDS.A Enchilada platform in the Gulf of...

Zacks Investment Research
Glaxo's Subcutaneous Formulation Of Benlysta Approved In EU By Zacks Investment Research - Nov 13, 2017

GlaxoSmithKline plc (NYSE:GSK) announced approval in EU for a new self-injectable subcutaneous ("SC") formulation of Benlysta for systemic lupus erythematosus ("SLE"). The subcutaneous formulation...

Zacks Investment Research
Trade Desk (TTD) Beats On Q3 Earnings & Revenues, Guides Up By Zacks Investment Research - Nov 13, 2017

The Trade Desk Inc. (NASDAQ:TTD) reported third-quarter 2017 earnings of 35 cents per share, which beat the Zacks Consensus Estimate by 9 cents. Moreover, the figure improved 45.8% from the year-ago...

Zacks Investment Research
Snapchat Launches ESPN SportsCenter Program On Its Platform By Zacks Investment Research - Nov 13, 2017

Per a recent article by TechCrunch, Snap Inc.’s (NYSE:SNAP) messaging application Snapchat has added Walt Disney (NYSE:DIS) owned sports television channel ESPN’s SportsCenter show to...

Zacks Investment Research
Itron Extends SMECO Contract, Offers Outsourced Solution By Zacks Investment Research - Nov 13, 2017

Itron, Inc. (NASDAQ:ITRI) recently extended its contract with Southern Maryland Electric Cooperative (SMECO) by three years to provide pay-for-performance demand-response solution.The partnership...

Zacks Investment Research
Avon (AVP) Down 66% In A Year: Will The Trend Continue? By Zacks Investment Research - Nov 13, 2017

Avon Products, Inc. (NYSE:AVP) has underperformed the industry in the past year owing to its dismal earnings surprise history. In fact, third-quarter 2017 also marked the company’s fifth...

Zacks Investment Research
Cenovus (CVE) Sells Weyburn Assets To Whitecap Resources By Zacks Investment Research - Nov 13, 2017

Cenovus Energy Inc. (TO:CVE) recently agreed to divest its carbon dioxide enhanced oil recovery operation, Weyburn oil facility in Saskatchewan for C$940 million ($738.53 million) to Whitecap...

Zacks Investment Research
Will Multiple Headwinds Hurt Campbell's (CPB) Q1 Earnings? By Zacks Investment Research - Nov 13, 2017

Campbell Soup Company (NYSE:CPB) is slated to release first-quarter fiscal 2018 results on Nov 21. The question lingering in investors’ minds is, whether this convenience foods behemoth will...

Zacks Investment Research
Steer Clear Of GE, Bet On These Industrial ETFs Instead By Zacks Investment Research - Nov 13, 2017

The industrial conglomerate giant, General Electric (NYSE:GE) , saw the steepest one-day decline since April 2009 after it slashed dividend and issued a downbeat profit guidance.The stock lost as...

Zacks Investment Research
Outfront Activates Signage Screen At Yonge-Dundas Square By Zacks Investment Research - Nov 13, 2017

Outfront Media (NYSE:OUT) announced that it has activated the first set of the five digital screens at the Yonge-Dundas Square (NYSE:SQ), Toronto. This marks the completion of a phase of the...

Zacks Investment Research
Digital Realty Expands In Europe With Frankfurt Facility By Zacks Investment Research - Nov 13, 2017

Digital Realty Trust, Inc. (NYSE:DLR) recently unveiled its second data center in Frankfurt, further expanding its presence in Europe. The latest nine-megawatt facility is, in fact, one of the three...

Zacks Investment Research
Orexigen (OREX) Q3 Loss Narrower Than Expected, Stock Up By Zacks Investment Research - Nov 13, 2017

Orexigen Therapeutics, Inc (NASDAQ:OREX) reported net loss of $1.35 per share for the third quarter of 2017, which was narrower than the Zacks Consensus Estimate of a loss of $2.13. The company had...

Continue with Apple
Continue with Google
or
Sign up with Email